ClinicalTrials.Veeva

Menu

HOMA-IR as a Screening Test in NAFLD

F

Fayoum University

Status

Completed

Conditions

NAFLD

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to evaluate the role of HOMA-IR in diagnosis of NAFLD in patients with type 2 DM.

Full description

this study is a retrospective cohort study included 100 patients with type 2 DM from the outpatient clinic of internal medicine department at Fayoum University Hospital. They were divided into two equal groups according to the presence of NAFLD by ultrasound. All patients were subjected to history taking, clinical examination and investigations which included: ALT, AST, total cholesterol, TG, FBG and fasting insulin level,HOMA-IR(Homeostatic Model Assessment for Insulin Resistance) assessment.

Enrollment

100 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetes obesity

Exclusion criteria

  • use of alcohol

Trial design

100 participants in 2 patient groups

Diabetics with NAFLD
Description:
Diabetics whose abdominal ultrasound showed that they have NAFLD
Diabetics without NAFLD
Description:
Diabetics whose abdominal ultrasound showed that they do not have NAFLD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems